| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/24/2012 | US8101586 Methods and compositions for the treatment of sterile inflammation |
| 01/24/2012 | US8101584 A mammalian target gene and an exogenous oligoribonucleotide having a double stranded RNA; complementary region I is less than 49 nucleotides in length; cancer, viral diseases, neurodegenerative diseases |
| 01/24/2012 | US8101412 Method of enhancing proliferation and/or hematopoietic differentiation of stem cells |
| 01/24/2012 | US8101370 Genes from the 20q13 amplicon and their uses |
| 01/24/2012 | US8101348 RNA-interference by single-stranded RNA molecules |
| 01/24/2012 | US8101347 Method and compositions for immunization with the Pseudomonas V antigen |
| 01/24/2012 | US8101343 protecting against parasites and predators; transgenic organisims |
| 01/24/2012 | US8101188 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 01/24/2012 | US8101174 Tumor necrosis factor cleaving agent for use in diagnosis, prevention and treatment of inflammatory disorders |
| 01/24/2012 | US8101170 Probiotic health or fitness promoting human or animal foodstuff and/or drinking water additive and use thereof |
| 01/24/2012 | US8101169 Ocular gene therapy using avalanche-mediated transfection |
| 01/24/2012 | CA2518169C A recombinant constructed by a virus vector and a human tumor suppressor gene and its use |
| 01/24/2012 | CA2508763C Human antibody producing mouse and method for producing human antibody using the same |
| 01/24/2012 | CA2480567C Mixed-cell gene therapy |
| 01/24/2012 | CA2455227C Use of biologically active hiv-1 tat, fragments or derivates thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 01/24/2012 | CA2410828C Duplexed parvovirus vectors |
| 01/24/2012 | CA2406168C Polyamide nucleic acid derivatives, agents and methods for producing same |
| 01/24/2012 | CA2370763C Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 01/24/2012 | CA2260754C Novel vegf-like factor |
| 01/19/2012 | WO2012009711A2 Retrovirus detection |
| 01/19/2012 | WO2012009508A2 Microrna compositions and methods related thereto |
| 01/19/2012 | WO2012009499A2 Assessing thyroid neoplasms and treating cancer |
| 01/19/2012 | WO2012009402A2 Treatment of discs large homolog (dlg) related diseases by inhibition of natural antisense transcript to dlg |
| 01/19/2012 | WO2012009347A2 Treatment of bcl2 binding component 3 (bbc3) related diseases by inhibition of natural antisense transcript to bbc3 |
| 01/19/2012 | WO2012009337A2 Nlrc5 as a target to intervene mhc class 1-mediated immune responses |
| 01/19/2012 | WO2012008465A1 (nucleic acid)-polysaccharide complex |
| 01/19/2012 | WO2012008302A1 Method for preparing novel hipsc by means of mirna introduction |
| 01/19/2012 | WO2012008301A1 Method for producing novel hipsc by means of sirna introduction |
| 01/19/2012 | WO2012007632A1 Use of edg2 inhibitors for treating rheumatoid arthritis |
| 01/19/2012 | WO2012007458A1 Gene therapy composition for use in diabetes treatment |
| 01/19/2012 | WO2011153493A3 Biodegradable lipids for the delivery of active agents |
| 01/19/2012 | WO2011130491A3 Methods and compositions for treating hiv |
| 01/19/2012 | WO2011112983A3 Psrp is a protective antigen against pneumococcal infection |
| 01/19/2012 | WO2011109398A3 Methods and compositions for treatment of angelman syndrome and autism spectrum disorders |
| 01/19/2012 | WO2011103528A3 Treatment of pyrroline-5-carboxylate reductase 1 (pycr1) related diseases by inhibition of natural antisense transcript to pycr1 |
| 01/19/2012 | US20120017288 Anticoagulant Fusion Protein Anchored to Cell Membrane |
| 01/19/2012 | US20120016340 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 01/19/2012 | US20120016008 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN RIBOSOMAL PROTEIN L26 (RIBO26) |
| 01/19/2012 | US20120015865 Novel class of cationic lipids for transporting active agents into cells |
| 01/19/2012 | US20120015820 Methods and compositions for polypeptide engineering |
| 01/19/2012 | US20120015402 Method of Proliferating Plasma Cells |
| 01/19/2012 | US20120015345 Identification of Oligonucleotides for the Capture, Detection and Quantitation of West Nile Virus |
| 01/19/2012 | US20120015042 Rna sequence-specific mediators of rna interference |
| 01/19/2012 | US20120015037 Functionalized nanoparticle, method for preparing the same and application thereof |
| 01/19/2012 | US20120014981 Avirulent, immunogenic flavivirus chimeras |
| 01/19/2012 | US20120014965 Compositions and methods of treating tumors |
| 01/19/2012 | US20120014959 Wise/sost nucleic acid sequences and amino acid sequences |
| 01/19/2012 | US20120014948 Genetic products differentially expressed in tumors and use thereof |
| 01/19/2012 | US20120014879 USE OF TUMOR NECROSIS FACTOR-alpha RECEPTOR p75 FOR TREATMENT OF ISCHEMIA-INDUCED NEOVASCULARIZATION |
| 01/19/2012 | CA2805318A1 Treatment of discs large homolog (dlg) related diseases by inhibition of natural antisense transcript to dlg |
| 01/19/2012 | CA2805170A1 Gene therapy composition for use in diabetes treatment |
| 01/19/2012 | CA2803011A1 Retrovirus detection |
| 01/18/2012 | EP2407171A2 Compositions and methods for the treatment of ophthalmic disease |
| 01/18/2012 | EP2406395A1 Diagnosis and treatment of cell proliferation and differentiation disorders based on the fmn2 gene |
| 01/18/2012 | EP2405945A2 Non-integrating retroviral vector vaccines |
| 01/18/2012 | EP1668120B1 Method for detecting cancer cells and monitoring cancer therapy |
| 01/18/2012 | EP1446489B1 Intact minicells as vectors for dna transfer and gene therapy in vitro and in vivo |
| 01/18/2012 | EP1390075B1 Chemotherapeutic induction of egr-1 promoter activity in gene therapy |
| 01/18/2012 | EP1013661B1 2'-O,4'-C-methylene bicyclonucleosides |
| 01/18/2012 | CN102321760A Non-small cell lung cancer (NSCLC) marker and its application |
| 01/18/2012 | CN102321654A Colon specific expression vector and construction method and application thereof |
| 01/18/2012 | CN102321652A Dual expression vector of immunostimulatory RNA and liver cancer target gene Pim-3 silent RNA and application thereof |
| 01/18/2012 | CN102321638A New porcine reproductive and respiratory syndrome virus ORF5 modified gene and application thereof |
| 01/18/2012 | CN102321637A Chinese fowlpox virus 282E4 low virulent strain complete genome sequence and application thereof |
| 01/18/2012 | CN102321628A C-type agglutinin gene of procambarus clarkia as well as preparation method and applications thereof |
| 01/18/2012 | CN102321626A Means for inhibiting the expression of protein kinase 3 |
| 01/18/2012 | CN102321625A Small molecular double stranded RNA group prepared from yeast, preparation method and use thereof |
| 01/18/2012 | CN102321584A Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence |
| 01/18/2012 | CN102321242A Polyethylene glycol-polylactic acid-poly-L-lysine copolymer, preparation method thereof and application thereof as gene or drug vector |
| 01/18/2012 | CN102321158A Polypeptide for preventing cell DNA synthesis and inhibiting cell proliferation and application |
| 01/18/2012 | CN102319441A Preparation method of PLGA swine influenza DNA vaccine microsphere |
| 01/18/2012 | CN102319440A Preparation method of porcine parvovirus genetic engineering vaccine |
| 01/18/2012 | CN101797387B Magnetic targeting carrier capable of carrying gene and drug, preparation method and application thereof |
| 01/18/2012 | CN101491670B Method for treating cardiovascular disease using nervous regulation protein and composite |
| 01/17/2012 | US8097716 Interfering RNA duplex having blunt-ends and 3′-modifications |
| 01/17/2012 | US8097711 nucleoside monomers protected with thioether substituted aryl carbonate protecting groups; oligonucleotides, using such protected nucleoside monomer monomers, as well as nucleic acids |
| 01/17/2012 | US8097647 Augmented cognitive training |
| 01/17/2012 | US8097598 Porcine CTLA-4 for xenograft-specific immunosuppression |
| 01/17/2012 | US8097597 Use of low doses of oligonucleotides antisense to TGF-β genes in the treatment of brain tumors |
| 01/17/2012 | US8097596 Compositions and methods for the treatment of muscle wasting |
| 01/17/2012 | US8097277 Charge-dynamic polymers and delivery of anionic compounds |
| 01/17/2012 | US8097257 MAGE3 polypeptides |
| 01/17/2012 | US8097255 Mammalian receptor protein DCRS5; methods of treatment |
| 01/17/2012 | US8097243 Microparticle-based transfection and activation of dendritic cells |
| 01/17/2012 | US8097242 Using cancer antigen 125 as tool in generating transmembrane serine protease inhibitory compound for treatment of urogenital cell proliferative disorders |
| 01/17/2012 | US8096419 Compound |
| 01/17/2012 | CA2583009C Ubiquitin or gamma-crystalline conjugates for use in therapy, diagnosis and chromatography |
| 01/17/2012 | CA2482440C Oligomeric compounds having modified phosphate groups |
| 01/17/2012 | CA2427916C Surface transfection and expression procedure |
| 01/17/2012 | CA2414542C Method for introducing nucleic acids and other biologically active molecules into the nucleus of higher eukaryotic cells using electric current |
| 01/17/2012 | CA2264191C Recombinant toxin fragments |
| 01/17/2012 | CA2148712C Peripheralization of hematopoietic stem cells |
| 01/12/2012 | WO2012006551A2 Neuroprotective molecules and methods of treating neurological disorders and inducing stress granules |
| 01/12/2012 | WO2012006512A1 Adenovirus ad36 e4orf1 protein for prevention and treatment of non-alcoholic fatty liver disease |
| 01/12/2012 | WO2012006377A2 Delivery of rna to trigger multiple immune pathways |
| 01/12/2012 | WO2012006369A2 Immunisation of large mammals with low doses of rna |
| 01/12/2012 | WO2012006243A2 Methods and compositions for the specific inhibition of beta-catenin by double-stranded rna |
| 01/12/2012 | WO2012006241A2 Methods and compositions for the specific inhibition of androgen receptor by double-stranded rna |
| 01/12/2012 | WO2012006181A2 Compositions and methods for inhibiting oncogenic micrornas and treatment of cancer |
| 01/12/2012 | WO2012006145A2 Com positions and methods for retargeting virus constructs |